Yuang Chen

About

Postdoctoral Associate Professor Daniel G. Anderson Lab David H. Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology

Work

Massachusetts Institute of Technology
|

Postdoctoral Associate

US

→

Education

University of Pittsburgh
United States of America

→

Ph.D.

Publications

The lncRNA EPIC1 suppresses dsRNA-induced type I IFN signaling and is a therapeutic target to enhance TNBC response to PD-1 inhibition

Published by

Science Signaling

Summary

journal-article

The lncRNA EPIC1 suppresses dsRNA-induced type I IFN signaling and is a therapeutic target to enhance TNBC response to PD-1 inhibition

Published by

Science Signaling

Summary

journal-article

Rational development of gemcitabine-based nanoplatform for targeting SERPINB9/Granzyme B axis to overcome chemo-immune-resistance

Published by

Nature Communications

Summary

journal-article

Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy

Published by

Nature Communications

Summary

journal-article

Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy

Published by

Nature Nanotechnology

Summary

journal-article

Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response

Published by

Science Advances

Summary

journal-article

Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophages

Published by

Acta Pharmaceutica Sinica B

Summary

journal-article

Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination.

Published by

Molecular therapy. Nucleic acids

Summary

journal-article